Goldman Sachs’s Otonomy, Inc. OTIC Stock Holding History

Goldman Sachs’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-37,500	Closed	-$459K	–	7052
2017 Q1	$459K	Buy	+37,500	New	+$546K	﹤0.01%	5111

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's OTIC Position: Q3 2021 in Review

Goldman Sachs sold out of Otonomy, Inc. (OTIC) in Q3 2021, closing a stake of 14,145 shares — an estimated $32K sold.

Goldman Sachs first reported a position in OTIC in Q3 2014 and held it in 27 quarters. The position peaked at $14.9M in Q1 2015. 55 funds tracked by Wall St. Rank hold OTIC as of Q3 2021.

Goldman Sachs reported no remaining Otonomy, Inc. position as of Q3 2021 after selling out during the quarter.
Goldman Sachs sold 14,145 Otonomy, Inc. shares in Q3 2021, an estimated $32K.
Goldman Sachs first reported a position in Otonomy, Inc. in Q3 2014 and held it in 27 quarters.
Goldman Sachs's Otonomy, Inc. position peaked at $14.9M in Q1 2015.
55 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.